Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/13/26 21:42 | 4/13/26 | MLYS | Health | Drug | Pharmaceutical Preparations | Rodman David Malcom | PA | O | Chief Me | 22 | S.dm | -15,259 | 29.54 | 0 | -517 | 117 | D | |||||||||||||||
4/15/26 21:45 | 4/13/26 | MLYS | Health | Drug | Pharmaceutical Preparations | Congleton Jon | PA | DO | CEO | 8 | S | -13,238 | 35.62 | 0 | -372 | 878 | D | |||||||||||||||
4/2/26 18:53 | 11/13/25 | MLYS | Health | Drug | Pharmaceutical Preparations | Karydas Daphne | PA | D | 2 | S.d | -765 | 42.49 | 0 | -18 | 6 | D | ||||||||||||||||
1/13/26 20:43 | 11/11/25 | MLYS | Health | Drug | Pharmaceutical Preparations | Levy Adam Scott | PA | O | CFO,Secr | 7 | S.dm | -7,622 | 30.86 | 0 | -247 | 226 | D | |||||||||||||||
11/21/25 18:07 | 11/20/25 | MLYS | Health | Drug | Pharmaceutical Preparations | Slingsby Brian Taylor | WA | DT | 1 | S | -43,350 | 43.35 | 0 | -1,000 | 7,904 | I | ||||||||||||||||
11/13/25 19:01 | 11/11/25 | MLYS | Health | Drug | Pharmaceutical Preparations | Gold Alexander M | PA | D | 1 | S.dm | -1,576 | 45.45 | 0 | -35 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |